LSE - Delayed Quote GBp

International Biotechnology Ord (IBT.L)

568.00
+18.00
+(3.27%)
At close: May 16 at 4:35:03 PM GMT+1
Advanced Chart
Loading Chart for IBT.L
  • Previous Close 550.00
  • Open 552.08
  • Bid 564.00 x --
  • Ask 572.00 x --
  • Day's Range 550.00 - 576.80
  • 52 Week Range 480.00 - 802.84
  • Volume 147,790
  • Avg. Volume 89,164
  • Market Cap (intraday) 204.298M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 5.57
  • EPS (TTM) --
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: IBT.L

View More
View More

Performance Overview: IBT.L

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

IBT.L
16.72%
FTSE 100 (^FTSE)
6.26%

1-Year Return

IBT.L
11.49%
FTSE 100 (^FTSE)
2.91%

3-Year Return

IBT.L
4.25%
FTSE 100 (^FTSE)
16.34%

5-Year Return

IBT.L
20.73%
FTSE 100 (^FTSE)
49.74%

Compare To: IBT.L

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

IBT.L
International Biotechnology Ord
568.00
+3.27%
Mkt Cap GBp 204.298M
Industry Biotechnology
PTGX
Protagonist Therapeutics, Inc.
44.49
+0.18%
Mkt Cap 2.758B
Industry Biotechnology
KROS
Keros Therapeutics, Inc.
14.07
+0.29%
Mkt Cap 571.459M
Industry Biotechnology
ARVN
Arvinas, Inc.
6.49
+3.67%
Mkt Cap 473.714M
Industry Biotechnology
BBIO
BridgeBio Pharma, Inc.
33.84
+0.30%
Mkt Cap 6.426B
Industry Biotechnology
ALNY
Alnylam Pharmaceuticals, Inc.
285.31
+0.67%
Mkt Cap 37.201B
Industry Biotechnology
EDIT
Editas Medicine, Inc.
1.5100
+8.24%
Mkt Cap 126.406M
Industry Biotechnology
HALO
Halozyme Therapeutics, Inc.
52.02
+6.27%
Mkt Cap 6.41B
Industry Biotechnology
EXEL
Exelixis, Inc.
45.40
-1.86%
Mkt Cap 12.381B
Industry Biotechnology

Statistics: IBT.L

View More

Valuation Measures

As of 5/16/2025

  • Market Cap

    199.33M

  • Enterprise Value

    --

  • Trailing P/E

    11.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.28

  • Price/Book (mrq)

    0.73

  • Enterprise Value/Revenue

    12.66

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: IBT.L

View More
View More

People Also Watch

BIOG.L Biotech Growth Ord
712.00
+2.89%
 
WWH.L Worldwide Healthcare Ord
286.00
+2.33%
 
PCT.L Polar Capital Technology Ord
330.50
-0.30%
 
FGT.L Finsbury Growth & Income Ord
932.00
+0.65%
 
HSL.L Henderson Smaller Companies Ord
836.00
+0.48%
 
BRWM.L BlackRock World Mining Trust Ord
481.00
+0.21%
 
ATT.L Allianz Technology Trust Ord
401.00
-0.37%
 
EWI.L Edinburgh Worldwide Ord
165.60
+0.85%
 
HRI.L Herald Ord
2,200.00
+1.15%
 
BGS.L Baillie Gifford Shin Nippon Ord
114.20
+0.88%
 
HFEL.L Henderson Far East Income Ord
216.50
+0.46%
 
EAT.L European Assets Ord
85.60
0.00%
 
TRY.L TR Property Ord
318.00
+0.95%
 
MYI.L Murray International Ord
275.00
0.00%
 
THRG.L BlackRock Throgmorton Trust Ord
578.00
+1.05%
 
EGL.L Ecofin Global Utilities & Infra Ord
209.00
+1.46%